Lip GYH - Search Results

1

Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.

Bucci T, Romiti GF, Shantsila A, Teo WS, Park HW, Shimizu W, Corica B, Proietti M, Tse HF, Chao TF, Frost F, Lip GYH; Asia‐Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. Bucci T, et al. Among authors: lip gyh. J Am Heart Assoc. 2024 Apr 2;13(7):e032785. doi: 10.1161/JAHA.123.032785. Epub 2024 Mar 27. J Am Heart Assoc. 2024. PMID: 38533983 Free PMC article.

2

Management of atrial fibrillation.

Lip GY, Tse HF. Lip GY, et al. Lancet. 2007 Aug 18;370(9587):604-18. doi: 10.1016/S0140-6736(07)61300-2. Lancet. 2007. PMID: 17707756 Review.

3

Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule.

Lim HS, Lip GY, Tse HF. Lim HS, et al. Europace. 2008 May;10(5):536-9. doi: 10.1093/europace/eun070. Epub 2008 Mar 26. Europace. 2008. PMID: 18367548 Review.

4

ACP Journal Club. Review: Combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure.

Shantsila A, Lip GY. Shantsila A, et al. Ann Intern Med. 2009 Aug 18;151(4):JC2-11. doi: 10.7326/0003-4819-151-4-200908180-02011. Ann Intern Med. 2009. PMID: 19687485 No abstract available.

5

Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure.

Shantsila A, Lip GY. Shantsila A, et al. Evid Based Med. 2009 Oct;14(5):142. doi: 10.1136/ebm.14.5.142. Evid Based Med. 2009. PMID: 19794017 No abstract available.

6

Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.

Siu CW, Watson T, Lai WH, Lee YK, Chan YH, Ng KM, Lau CP, Lip GY, Tse HF. Siu CW, et al. Europace. 2010 Apr;12(4):517-21. doi: 10.1093/europace/eup382. Epub 2009 Nov 30. Europace. 2010. PMID: 19951966

7

Malignant hypertension: a rare problem or is it underdiagnosed?

Shantsila A, Shantsila E, Lip GY. Shantsila A, et al. Curr Vasc Pharmacol. 2010 Nov;8(6):775-9. doi: 10.2174/157016110793563834. Curr Vasc Pharmacol. 2010. PMID: 20626341 Review.

8

Persistent macrovascular and microvascular dysfunction in patients with malignant hypertension.

Shantsila A, Dwivedi G, Shantsila E, Butt M, Beevers DG, Lip GY. Shantsila A, et al. Hypertension. 2011 Mar;57(3):490-6. doi: 10.1161/HYPERTENSIONAHA.110.166314. Epub 2011 Jan 24. Hypertension. 2011. PMID: 21263115

9

The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution?

Lip GYH, Halperin JL, Tse HF. Lip GYH, et al. Chest. 2011 Apr;139(4):738-741. doi: 10.1378/chest.10-2763. Chest. 2011. PMID: 21467053 No abstract available.

10

Ethnic differences in macrovascular and microvascular function in systolic heart failure.

Shantsila E, Wrigley B, Shantsila A, Tapp LD, Blann AD, Gill PS, Lip GY. Shantsila E, et al. Circ Heart Fail. 2011 Nov;4(6):754-62. doi: 10.1161/CIRCHEARTFAILURE.111.962365. Epub 2011 Sep 13. Circ Heart Fail. 2011. PMID: 21914813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,643 results

Search Page

Filters